The convergence of artificial intelligence and genomics is revolutionizing the field, with a recent study uncovering nearly 800 genetic changes that directly impact survival outcomes across 20 cancer types.
The research, which analyzed data from over 78,000 cancer patients, has identified 95 genes significantly associated with survival in cancers such as breast, ovarian, skin, and gastrointestinal cancers, underscoring the critical role of genetic mutations in influencing treatment response.
With the development of a machine learning tool to predict patient responses to immunotherapy, the study highlights the potential for precision medicine to tailor treatments to individual genetic profiles, potentially avoiding ineffective therapies and focusing on those most likely to help.
Key findings from the study include the impact of KRAS mutations on non-small cell lung cancer treatment outcomes, the complex role of NF1 mutations in treatment response, and the varying effects of PI3K pathway mutations across different cancer types. As cancer treatment increasingly shifts towards a personalized approach, this research underscores the importance of integrating large-scale real-world data with advanced computational methods to refine treatment recommendations and expand access to immunotherapy.
Cancer treatment has long been a one-size-fits-all approach, where patients with the same type of cancer receive the same standard therapies. However, this is changing rapidly with the advent of advanced computational methods and genomics.
A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes. These insights could help doctors tailor treatments more effectively. This article delves into the complexities of cancer treatment, exploring how AI and genomics personalize patient care.
Genetic mutations and changes in DNA can influence how cancer develops and how a patient responds to treatment. Some mutations occur randomly, while others are inherited. In cancer, mutations can determine whether a tumor is more aggressive or how it might respond to certain treatments. Today, genetic testing is increasingly used in cancer care to identify these mutations, allowing doctors to select treatments more precisely.
The study analyzed data for more than 78,000 cancer patients across 20 cancer types and identified nearly 800 genetic changes that directly impacted survival outcomes. The researchers also discovered 95 genes significantly associated with survival in cancers such as breast, ovarian, skin, and gastrointestinal cancers. Some key findings include:
- KRAS mutations in advanced non-small cell lung cancer were linked to poorer response to a common treatment (EGFR inhibitors), suggesting alternative treatments may be needed.
- NF1 mutations improved responses to immunotherapy and worsened responses to certain targeted therapies, highlighting their complex role in treatment.
- PI3K pathway mutations, which regulate cell growth, had varying effects depending on cancer type, with different responses in breast, melanoma, and renal cancers.
To bridge the gap between vast amounts of mutation data and clinically validated treatments, Liu’s team used machine learning to analyze how multiple mutations interact to influence treatment outcomes. They developed a Random Survival Forest (RSF) model, a predictive tool designed to refine treatment recommendations for lung cancer patients. By integrating large-scale real-world data with machine learning, the model identified new mutation-treatment interactions.
The study highlights the critical roles of genes such as TP53, CDKN2A, and CDKN2B in influencing treatment outcomes, validating these associations with real-world data. While further clinical trials are needed, Liu sees this study as an important step toward making cancer treatment more precise and personalized. The integration of AI and genomics has the potential to revolutionize patient care, enabling doctors to select the most effective therapies and avoid ineffective ones.
External Link: Click Here For More
